Platelet activation in cats with hypertrophic cardiomyopathy

Fern Tablin, T. Schumacher, M. Pombo, C. T. Marion, K. Huang, J. W. Norris, Karl Jandrey, Mark D Kittleson

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Cats with hypertrophic cardiomyopathy (HCM) are at risk for development of systemic thromboembolic disease. However, the relationship between platelet activation state and cardiovascular parameters associated with HCM is not well described. Objectives: To characterize platelet activation by flow cytometric evaluation of platelet P-selectin and semiquantitative Western blot analysis of soluble platelet-endothelial cell adhesion molecule-1 (sPECAM-1). Animals: Eight normal healthy cats (controls) owned by staff and students of the School of Veterinary Medicine and 36 cats from the UC Davis Feline HCM Research Laboratory were studied. Methods: Platelet-rich plasma (PRP) was used for all flow cytometry studies. Platelet surface CD41 and P-selectin expression were evaluated before and after ADP stimulation. sPECAM-1 expression was evaluated by Western blot analysis of platelet-poor plasma that had been stabilized with aprotinin. Standard echocardiographic studies were performed. Results: Resting platelets from cats with severe HCM had increased P-selectin expression compared to controls, and expressed higher surface density of P-selectin reflected by their increased mean fluorescence intensities (MFI). Stimulation with ADP also resulted in significantly increased P-selectin MFI of platelets from cats with severe HCM. Increased P-selectin expression and MFI correlated with the presence of a heart murmur and end-systolic cavity obliteration (ESCO). sPECAM-1 expression from cats with moderate and severe HCM was significantly increased above those of control cats. Conclusions and Clinical Importance: P-selectin and sPECAM expression may be useful biomarkers indicating increased platelet activation in cats with HCM.

Original languageEnglish (US)
Pages (from-to)411-418
Number of pages8
JournalJournal of Veterinary Internal Medicine
Volume28
Issue number2
DOIs
StatePublished - Mar 2014

Fingerprint

platelet activation
Hypertrophic Cardiomyopathy
cardiomyopathy
Platelet Activation
P-Selectin
Cats
cats
CD31 Antigens
Blood Platelets
cell adhesion
endothelial cells
Fluorescence
fluorescence
Adenosine Diphosphate
Western Blotting
Western blotting
Heart Murmurs
Aprotinin
Platelet-Rich Plasma
Veterinary Medicine

Keywords

  • Hypertrophic cardiomyopathy
  • P-selectin
  • Platelet activation
  • Platelets
  • sPECAM-1

ASJC Scopus subject areas

  • veterinary(all)
  • Medicine(all)

Cite this

Platelet activation in cats with hypertrophic cardiomyopathy. / Tablin, Fern; Schumacher, T.; Pombo, M.; Marion, C. T.; Huang, K.; Norris, J. W.; Jandrey, Karl; Kittleson, Mark D.

In: Journal of Veterinary Internal Medicine, Vol. 28, No. 2, 03.2014, p. 411-418.

Research output: Contribution to journalArticle

Tablin, F, Schumacher, T, Pombo, M, Marion, CT, Huang, K, Norris, JW, Jandrey, K & Kittleson, MD 2014, 'Platelet activation in cats with hypertrophic cardiomyopathy', Journal of Veterinary Internal Medicine, vol. 28, no. 2, pp. 411-418. https://doi.org/10.1111/jvim.12325
Tablin, Fern ; Schumacher, T. ; Pombo, M. ; Marion, C. T. ; Huang, K. ; Norris, J. W. ; Jandrey, Karl ; Kittleson, Mark D. / Platelet activation in cats with hypertrophic cardiomyopathy. In: Journal of Veterinary Internal Medicine. 2014 ; Vol. 28, No. 2. pp. 411-418.
@article{7359c3f300bc4fc982bfa7451334c8df,
title = "Platelet activation in cats with hypertrophic cardiomyopathy",
abstract = "Background: Cats with hypertrophic cardiomyopathy (HCM) are at risk for development of systemic thromboembolic disease. However, the relationship between platelet activation state and cardiovascular parameters associated with HCM is not well described. Objectives: To characterize platelet activation by flow cytometric evaluation of platelet P-selectin and semiquantitative Western blot analysis of soluble platelet-endothelial cell adhesion molecule-1 (sPECAM-1). Animals: Eight normal healthy cats (controls) owned by staff and students of the School of Veterinary Medicine and 36 cats from the UC Davis Feline HCM Research Laboratory were studied. Methods: Platelet-rich plasma (PRP) was used for all flow cytometry studies. Platelet surface CD41 and P-selectin expression were evaluated before and after ADP stimulation. sPECAM-1 expression was evaluated by Western blot analysis of platelet-poor plasma that had been stabilized with aprotinin. Standard echocardiographic studies were performed. Results: Resting platelets from cats with severe HCM had increased P-selectin expression compared to controls, and expressed higher surface density of P-selectin reflected by their increased mean fluorescence intensities (MFI). Stimulation with ADP also resulted in significantly increased P-selectin MFI of platelets from cats with severe HCM. Increased P-selectin expression and MFI correlated with the presence of a heart murmur and end-systolic cavity obliteration (ESCO). sPECAM-1 expression from cats with moderate and severe HCM was significantly increased above those of control cats. Conclusions and Clinical Importance: P-selectin and sPECAM expression may be useful biomarkers indicating increased platelet activation in cats with HCM.",
keywords = "Hypertrophic cardiomyopathy, P-selectin, Platelet activation, Platelets, sPECAM-1",
author = "Fern Tablin and T. Schumacher and M. Pombo and Marion, {C. T.} and K. Huang and Norris, {J. W.} and Karl Jandrey and Kittleson, {Mark D}",
year = "2014",
month = "3",
doi = "10.1111/jvim.12325",
language = "English (US)",
volume = "28",
pages = "411--418",
journal = "Journal of Veterinary Internal Medicine",
issn = "0891-6640",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Platelet activation in cats with hypertrophic cardiomyopathy

AU - Tablin, Fern

AU - Schumacher, T.

AU - Pombo, M.

AU - Marion, C. T.

AU - Huang, K.

AU - Norris, J. W.

AU - Jandrey, Karl

AU - Kittleson, Mark D

PY - 2014/3

Y1 - 2014/3

N2 - Background: Cats with hypertrophic cardiomyopathy (HCM) are at risk for development of systemic thromboembolic disease. However, the relationship between platelet activation state and cardiovascular parameters associated with HCM is not well described. Objectives: To characterize platelet activation by flow cytometric evaluation of platelet P-selectin and semiquantitative Western blot analysis of soluble platelet-endothelial cell adhesion molecule-1 (sPECAM-1). Animals: Eight normal healthy cats (controls) owned by staff and students of the School of Veterinary Medicine and 36 cats from the UC Davis Feline HCM Research Laboratory were studied. Methods: Platelet-rich plasma (PRP) was used for all flow cytometry studies. Platelet surface CD41 and P-selectin expression were evaluated before and after ADP stimulation. sPECAM-1 expression was evaluated by Western blot analysis of platelet-poor plasma that had been stabilized with aprotinin. Standard echocardiographic studies were performed. Results: Resting platelets from cats with severe HCM had increased P-selectin expression compared to controls, and expressed higher surface density of P-selectin reflected by their increased mean fluorescence intensities (MFI). Stimulation with ADP also resulted in significantly increased P-selectin MFI of platelets from cats with severe HCM. Increased P-selectin expression and MFI correlated with the presence of a heart murmur and end-systolic cavity obliteration (ESCO). sPECAM-1 expression from cats with moderate and severe HCM was significantly increased above those of control cats. Conclusions and Clinical Importance: P-selectin and sPECAM expression may be useful biomarkers indicating increased platelet activation in cats with HCM.

AB - Background: Cats with hypertrophic cardiomyopathy (HCM) are at risk for development of systemic thromboembolic disease. However, the relationship between platelet activation state and cardiovascular parameters associated with HCM is not well described. Objectives: To characterize platelet activation by flow cytometric evaluation of platelet P-selectin and semiquantitative Western blot analysis of soluble platelet-endothelial cell adhesion molecule-1 (sPECAM-1). Animals: Eight normal healthy cats (controls) owned by staff and students of the School of Veterinary Medicine and 36 cats from the UC Davis Feline HCM Research Laboratory were studied. Methods: Platelet-rich plasma (PRP) was used for all flow cytometry studies. Platelet surface CD41 and P-selectin expression were evaluated before and after ADP stimulation. sPECAM-1 expression was evaluated by Western blot analysis of platelet-poor plasma that had been stabilized with aprotinin. Standard echocardiographic studies were performed. Results: Resting platelets from cats with severe HCM had increased P-selectin expression compared to controls, and expressed higher surface density of P-selectin reflected by their increased mean fluorescence intensities (MFI). Stimulation with ADP also resulted in significantly increased P-selectin MFI of platelets from cats with severe HCM. Increased P-selectin expression and MFI correlated with the presence of a heart murmur and end-systolic cavity obliteration (ESCO). sPECAM-1 expression from cats with moderate and severe HCM was significantly increased above those of control cats. Conclusions and Clinical Importance: P-selectin and sPECAM expression may be useful biomarkers indicating increased platelet activation in cats with HCM.

KW - Hypertrophic cardiomyopathy

KW - P-selectin

KW - Platelet activation

KW - Platelets

KW - sPECAM-1

UR - http://www.scopus.com/inward/record.url?scp=84897633604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897633604&partnerID=8YFLogxK

U2 - 10.1111/jvim.12325

DO - 10.1111/jvim.12325

M3 - Article

C2 - 24612013

AN - SCOPUS:84897633604

VL - 28

SP - 411

EP - 418

JO - Journal of Veterinary Internal Medicine

JF - Journal of Veterinary Internal Medicine

SN - 0891-6640

IS - 2

ER -